Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR. Eric Davis, Louis M. Staudt, Weihong Xu et al.|Nature|2010Cited by 1.6k
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneNathalie A. Johnson, Randy D. Gascoyne, Graham W. Slack et al.|Journal of Clinical Oncology|2012Cited by 971
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survivalNathalie A. Johnson, Douglas E. Horsman|Blood|2009Cited by 582
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencingRyan D. Morin, Marco A. Marra, Karen Mungall et al.|Blood|2013Cited by 396
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher Rushton, Ryan D. Morin, Sarah E. Arthur et al.|Blood Advances|2020Cited by 120